Fortrea Holdings Inc. Board of Directors

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Ms. Hima B. Inguva

Ms. Hima B. Inguva

Head of Investor Relations & Corporate Development

Dr. John J. Doyle M.D.

Dr. John J. Doyle M.D.

Chief Scientific Officer & President of Consulting Services

Stillman Hanson

Stillman Hanson

General Counsel & Corporate Secretary

Ms. Jill McConnell

Ms. Jill McConnell

Chief Financial Officer

Mr. Mark A. Morais

Mr. Mark A. Morais

COO & President of Clinical Services

Mr. Drayton Virkler

Mr. Drayton Virkler

President & Chief Commercial Officer

Mr. Robert Parks

Mr. Robert Parks

Chief Accounting Officer

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.